137 related articles for article (PubMed ID: 2524313)
21. Comparison of aztreonam against other antibiotics used in urinary tract infections.
Khan MT; Shah SH
J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
[TBL] [Abstract][Full Text] [Related]
22. Aminoglycosides, imipenem, and aztreonam.
Johnson JG; Hardin TC
Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
[TBL] [Abstract][Full Text] [Related]
23. [Urinary tract infections due to multiresistant gram negative bacteria].
Acar JF; Guibert J; Bourquelot P; Brisset JM
Nouv Presse Med; 1974 Apr; 3(0):69-72. PubMed ID: 4209339
[No Abstract] [Full Text] [Related]
24. Treatment of urinary infections: clinical perspectives.
Fontana G; Laudi M; Carlone NA; Savoia D
Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
[TBL] [Abstract][Full Text] [Related]
25. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
26. Aztreonam, a new monobactam antimicrobial.
Guay DR; Koskoletos C
Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and tolerability of aztreonam in urinary tract infection caused by multiresistant bacteria.
Muzzonigro G; Minardi D; Caraceni E; Villanova A; Polito M
Acta Urol Belg; 1987; 55(3):485-90. PubMed ID: 3661329
[No Abstract] [Full Text] [Related]
28. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
[No Abstract] [Full Text] [Related]
30. [Urinary tract infection associated with urinary calculi. 2. Effects of antibiotics on bacteria within infected stones].
Takeuchi H; Okada Y; Yoshida O; Konishi T; Tomoyoshi T; Nakahara S
Hinyokika Kiyo; 1989 May; 35(5):755-61. PubMed ID: 2801373
[TBL] [Abstract][Full Text] [Related]
31. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A; Cortecchia V; Ventriglia L
Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
[No Abstract] [Full Text] [Related]
32. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotic treatment of urinary tract infections in hospitalized children].
Bianchetti MG; Markus-Vecerova D; Schaad UB
Schweiz Med Wochenschr; 1995 Feb; 125(6):201-6. PubMed ID: 7871402
[TBL] [Abstract][Full Text] [Related]
34. Carumonam in the treatment of severe and complicated urinary tract infections.
Kotilainen P; Huovinen P; Hänninen P
Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
[No Abstract] [Full Text] [Related]
35. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
[No Abstract] [Full Text] [Related]
37. In vitro studies with aztreonam, a new monobactam antibiotic.
Peddie BA
N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
[No Abstract] [Full Text] [Related]
38. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
Monaci E; Monaci R; Giacalone G; Meoni S
Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of combination therapy with Fortimicin and Cefotax in the treatment of complicated urinary tract infections].
Sakashita S; Asano Y; Togashi M; Maru A; Koyanagi T; Kasai T; Namiji T; Mitsuhashi K; Amino I; Kaneta T
Hinyokika Kiyo; 1987 Oct; 33(10):1718-23. PubMed ID: 3328504
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
Landinez R; Garcia M; Merino C
Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
